In CF patients, lung microbiome dysbiosis is already evident in the first years of life, and although the restoration of CFTR function with a combination of correctors and potentiators is proving to be the right path to follow, it might not be enough if a healthy/balanced microbiome is not restored. This evidence concerns the gene CFTR and cystic fibrosis.